REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/17/2025
Back to search
Official data from USPTO
TARGET HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TARGET HEALTH
ST13
US500000078313401Class
35, 41, 42, 44
Filing
78313401
Registration
3156025
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
10/18/2025
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
10/14/2003
Registration date
10/17/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2017
Last transaction
10/18/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1993-00-00
First use in commerce
1993-00-00
Drawing code
1
Owner type
16
Owner location
NEW YORK, NY
Examiner
KAZAZIAN,MICHAEL H
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
TARGET HEALTH, LLC
Target Health, Inc.
Representatives
Kenneth I. Kohn KOHN & ASSOCIATES, PLLC
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business auditing servicesperforming pre-inspection goods manufacturing practices audits and assuring that user fee monies are submitted; biostatistics and data processing services; providing statistical information; performing statistical analyses; manufacturer representatives in the field of pharmaceuticals
Class 41
Computer servicesproviding online journals in fields of health and medicine
Class 42
Providing quality assurance services in the field of pharmaceuticals; reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; consulting services regarding food and drug law and regulation compliancepreparing for and conducting meetings to discuss and negotiate development strategiespreparing and submitting documents and forms required by the FDApreparing responses to FDA questions and warning lettersfollow-up with FDA on post application submission questionspreparing for and conducting meetings with legal counseltroubleshooting product and process issuesperforming analytical methods development and validationdesigning and implementing safety and regulatory toxicology programs; intellectual property licensing in the fields of drugdrug productpharmaceutical and pharmaceutical products; medical and scientific researchconducting clinical trialsspecifically preparing protocolscase report forms and informed consent formsperforming qualificationinitiationmonitoring and closeout visitsgenerating investigator study filesmonitor drug supplyidentifying study sites and managing investigator paymentspreparing clinical sites for FDA inspection; consultation in the fields of drug developmentincluding working with sponsormedicalscientifictoxicologymanufacturing and business experts to clearly delineate development requirementsevaluating available and competitive technologies; product and process development services; technical writing for othersspecificallyintegrated clinical and statistical study reports and other regulatory manuscripts
Class 44
Providing an on-line database for use in gathering and providing patient records and patient data via a global computer network
Publications
History of USPTO decisions and trademark events.
28 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/12/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/14/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/14/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/14/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/12/2017
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
08/03/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
05/11/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
09/12/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/12/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2012
E815
TEAS SECTION 8 & 15 RECEIVED
08/20/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2006
PUBO
PUBLISHED FOR OPPOSITION
07/25/2006
NPUB
NOTICE OF PUBLICATION
07/05/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2006
ALIE
ASSIGNED TO LIE
05/31/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2006
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/15/2005
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/12/2005
CNSL
LETTER OF SUSPENSION MAILED
11/08/2004
CNSL
SUSPENSION LETTER WRITTEN
11/08/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
11/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2004
PAPER RECEIVED
10/20/2004
CNRT
NON-FINAL ACTION MAILED
05/11/2004
DOCK
ASSIGNED TO EXAMINER
04/26/2004
Continuous trademark protection
Get notified about every new filing that threatens TARGET HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.